In colorectal cancer, radiotherapy activates the PI3K/AKT signaling pathway, which in turn causes upregulation of SOX2 expression, ultimately leading to increased CD44+ cells and enhanced radioresistance44. This evidence concerns the gene SOX2 and colorectal cancer.